Advanced Enzyme

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE837H01020
  • NSEID: ADVENZYMES
  • BSEID: 540025
INR
286.00
20.45 (7.7%)
BSENSE

Feb 03

BSE+NSE Vol: 2.13 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
542.39
469.73
466.06
401.93
397.65
368.63
333.72
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
542.39
469.73
466.06
401.93
397.65
368.63
333.72
Raw Material Cost
138.35
116.01
119.55
92.00
96.04
70.41
70.71
Purchase of Finished goods
0.00
0.00
0.02
0.00
0.07
0.03
0.18
(Increase) / Decrease In Stocks
-2.33
-10.24
-10.51
6.24
-18.02
-1.77
-7.97
Employee Cost
120.35
104.70
95.71
84.84
78.03
63.88
60.07
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.00
0.00
-0.02
0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
120.18
110.43
112.20
106.55
80.46
59.44
57.12
Total Expenditure (Excl Depreciation)
376.56
320.90
316.97
289.63
236.56
192.00
180.10
Operating Profit (PBDIT) excl Other Income
165.83
148.83
149.09
112.30
161.09
176.63
153.62
Other Income
27.60
24.30
27.17
14.38
3.04
7.17
3.81
Operating Profit (PBDIT)
193.43
173.13
176.26
126.68
164.13
183.80
157.43
Interest
2.06
2.74
2.08
1.81
1.12
1.17
2.34
Exceptional Items
11.25
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
202.62
170.39
174.18
124.87
163.01
182.63
155.09
Depreciation
29.90
26.48
25.96
26.58
25.91
20.02
19.12
Profit Before Tax
172.73
143.90
148.21
98.28
137.11
162.60
135.96
Tax
44.38
36.66
41.14
26.53
38.57
44.93
35.59
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
128.35
107.25
107.08
71.75
98.55
117.66
100.37
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
128.35
107.25
107.08
71.75
98.55
117.66
100.37
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.24
-0.15
-0.63
-1.29
-1.25
-0.71
-0.51
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
125.76
104.64
104.99
73.52
95.15
114.53
97.97
Equity Capital
22.39
22.38
22.37
22.36
22.36
22.35
22.34
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
3.79
3.36
3.74
2.63
2.45
3.85
3.01
Operating Profit Margin (Excl OI)
30.57%
31.68%
31.99%
27.94%
40.51%
47.92%
46.03%
Gross Profit Margin
37.36%
36.27%
37.37%
31.07%
40.99%
49.54%
46.47%
PAT Margin
23.66%
22.83%
22.98%
17.85%
24.78%
31.92%
30.08%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 15.47% vs 0.79% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2025 is 20.18% vs -0.33% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 11.42% vs -0.17% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -24.82% vs 31.73% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024

Compare Nine Monthly Results Of Advanced Enzyme With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
542.39
0
542.39
Other Operating Income
0.00
0.00
0.00
Total Operating income
542.39
0
542.39
Raw Material Cost
138.35
0
138.35
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-2.33
0
-2.33
Employee Cost
120.35
0
120.35
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.01
0
0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
120.18
0.00
120.18
Total Expenditure (Excl Depreciation)
376.56
0
376.56
Operating Profit (PBDIT) excl Other Income
165.83
0.00
165.83
Other Income
27.60
0
27.60
Operating Profit (PBDIT)
193.43
0
193.43
Interest
2.06
0
2.06
Exceptional Items
11.25
0
11.25
Gross Profit (PBDT)
202.62
0
202.62
Depreciation
29.90
0
29.90
Profit Before Tax
172.73
0
172.73
Tax
44.38
0
44.38
Provisions and contingencies
0.00
0
0.00
Profit After Tax
128.35
0
128.35
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
128.35
0
128.35
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-1.24
0
-1.24
Other related items
0.00
0.00
0.00
Consolidated Net Profit
125.76
0
125.76
Equity Capital
22.39
0
22.39
Face Value
2.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
37.36%
0%
0.00
37.36%
PAT Margin
23.66%
0%
0.00
23.66%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 542.39 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 15.47% vs 0.79% in Dec 2024

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 125.76 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 20.18% vs -0.33% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 165.83 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 11.42% vs -0.17% in Dec 2024

Nine Monthly - Interest
Interest 2.06 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -24.82% vs 31.73% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.57%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024